U. of Chicago Booth School Presents Distinguished Alumni Award to Amy Ellis

Prestigious Award Recognizes Outstanding Professional Achievement

Hamilton, NJ (May 2, 2017) — MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that Amy Ellis, president and co-founder, has been selected to receive the Distinguished Alumni Award (DAA) from the University of Chicago Booth School of Business.

Araclon Biotech Selects MedAvante Virgil Platform for Phase 2 Alzheimer’s Trial

Shared Goal Is Improving Signal Detection and Data Quality through Standardization

Zaragoza, Spain and Hamilton NJ, USA (March 30, 2017) — Araclon Biotech, a Grifols company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, and MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, today announced that Araclon Biotech has selected MedAvante’s groundbreaking Virgil® Investigative Study Platform for its upcoming Phase 2 trial in prodromal or very mild Alzheimer’s disease (AD).

MedAvante Names Ropacki Head of Research and Development

Accomplished Clinical Scientist Will Accelerate Company’s Growth

Hamilton, NJ (February 22, 2017) — MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that Michael T. Ropacki, PhD, has been appointed Vice President, Research and Development to lead the company’s continued expansion of clinical science and signal detection capabilities.

Ian Neilson Joins MedAvante As Global IT Leader

Former Covance Executive Is Accomplished Technology Innovator

Hamilton, NJ (February 8, 2017) — MedAvante, Inc., the leading global clinical data services company dedicated to maximizing signal detection in clinical trials, announced that Ian C. Neilson has accepted the position of Senior Vice President, Global Information Technology to lead the company’s rapidly growing IT operations supporting clinical science and signal detection capabilities.

MedAvante Names Leader for Patient-Focused eSolutions

ePRO Expert Will Enhance Electronic Clinical Outcome Assessment Offerings

Hamilton, NJ (January 26, 2017) — MedAvante, Inc., the leader in technology-based clinical trial services for treatments of central nervous system (CNS) diseases, announced that Susan Vallow, RPh MBA MA, has assumed a new position as Vice President, Patient eSolutions, joining MedAvante from GSK where she was Senior Director and Head of Patient Focused Outcomes.

MedAvante Surpasses 630,000 Electronic Source (eSource) Clinical Trial Assessments

Extends Leadership Position in Electronic Clinical Outcome Assessments (eCOA)

Hamilton, NJ (November 15, 2016) — MedAvante, Inc., the leader in technology-based clinical trial services for central nervous system (CNS) diseases, announced significant advances in the deployment of the groundbreaking Virgil® Investigative Study Platform for global clinical trials as the source (eSource) data platform begins its third year in worldwide use.